Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, National Institutes of Health, US Department of Health and Human Services, 10 Center Drive, Bethesda, MD 20892-1061, USA.
European Heart Journal (Impact Factor: 14.72). 01/2012; 33(10):1268-78. DOI: 10.1093/eurheartj/ehr481
Source: PubMed

ABSTRACT Conventional late gadolinium enhancement (LGE) cardiac magnetic resonance can detect myocardial infarction and some forms of non-ischaemic myocardial fibrosis. However, quantitative imaging of extracellular volume fraction (ECV) may be able to detect subtle abnormalities such as diffuse fibrosis or post-infarct remodelling of remote myocardium. The aims were (1) to measure ECV in myocardial infarction and non-ischaemic myocardial fibrosis, (2) to determine whether ECV varies with age, and (3) to detect sub-clinical abnormalities in 'normal appearing' myocardium remote from regions of infarction.
Cardiac magnetic resonance ECV imaging was performed in 126 patients with T1 mapping before and after injection of gadolinium contrast. Conventional LGE images were acquired for the left ventricle. In patients with a prior myocardial infarction, the infarct region had an ECV of 51 ± 8% which did not overlap with the remote 'normal appearing' myocardium that had an ECV of 27 ± 3% (P < 0.001, n = 36). In patients with non-ischaemic cardiomyopathy, the ECV of atypical LGE was 37 ± 6%, whereas the 'normal appearing' myocardium had an ECV of 26 ± 3% (P < 0.001, n = 30). The ECV of 'normal appearing' myocardium increased with age (r = 0.28, P = 0.01, n = 60). The ECV of 'normal appearing' myocardium remote from myocardial infarctions increased as left ventricular ejection fraction decreased (r = -0.50, P = 0.02).
Extracellular volume fraction imaging can quantitatively characterize myocardial infarction, atypical diffuse fibrosis, and subtle myocardial abnormalities not clinically apparent on LGE images. Taken within the context of prior literature, these subtle ECV abnormalities are consistent with diffuse fibrosis related to age and changes remote from infarction.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart failure (HF) is a major and growing cause of morbidity and mortality. Despite initial successes, there have been few recent therapeutic advances. A better understanding of HF pathophysiology is needed with renewed focus on the myocardium itself. A new imaging technique is now available that holds promise. T1 mapping is a cardiovascular magnetic resonance (CMR) technique for non-invasive myocardial tissue characterization. T1 alters with disease. Pre-contrast (native) T1 changes with a number of processes such as fibrosis, edema and infiltrations. If a post contrast scan is also done, the extracellular volume fraction (ECV) can be measured, a direct measure of the interstitium and its reciprocal, the cell volume. This dichotomy is fundamental - and now measurable promising more targeted therapy and new insights into disease biology.
    Current Cardiovascular Imaging Reports 09/2014; 7:9287.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Increased aortic stiffness is related to increased ventricular stiffness and remodeling. Myocardial fibrosis is the pathophysiological hallmark of failing heart. We investigated the relationship between noninvasive imaging markers of myocardial fibrosis, native T1, and late gadolinium enhancement, respectively, and aortic stiffness in ventricular remodeling. Consecutive patients with known dilated cardiomyopathy (n=173) underwent assessment of cardiac volumes and function, T1 mapping, scar imaging, and pulse wave velocity, a measure of aortic stiffness. Asymptomatic healthy volunteers served as controls (n=47). Controls and patients showed an increase in pulse wave velocity with age, which was accelerated in the presence of cardiovascular disease. On the contrary, native T1 increased with age in patients, but not in controls. Pulse wave velocity was associated with native T1 in the presence of disease, but not in health. Native T1 showed a strong relationship with markers of structural and functional left ventricular remodeling and diastolic impairment. Ischemic and nonischemic pathophysiology of ventricular remodeling showed a similar slope of relationship between pulse wave velocity and native T1. However, in nonischemic patients, increase in pulse wave velocity was associated with greater increase in native T1. Aortic stiffness is related to age, and this process is accelerated in the presence of disease. On the contrary, increase in interstitial myocardial fibrosis is associated with age in the presence of disease. Patients with ischemic and nonischemic dilated cardiomyopathy have a similar relationship between native T1 and pulse wave velocity, which is stronger in the latter group.
    Hypertension 07/2014; · 6.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Endomyocardial biopsy for histological analysis is an important diag-nostic tool in non-ischaemic cardiomyopathy. However, endomyo-cardial biopsy is invasive and associated with some risk, albeit low. The diagnostic yield is also low, because (1) pathology is often hetero-geneous, (2) current interventional techniques do not permit tar-geted biopsy, and (3) histological analysis can be difficult. For these reasons, endomyocardial biopsy has lost favour among adult cardiol-ogists, except in cardiac transplant, where patients usually undergo serial biopsies to monitor graft health. Understandably, a non-invasive alternative to endomyocardial biopsy would be attractive to clinicians and patients alike. The great advantage of cardiovascular magnetic resonance (CMR) compared with other non-invasive imaging modalities is tissue char-acterization. Patterns of late gadolinium enhancement (LGE) can dif-ferentiate between viable and infarcted myocardium, and between ischaemic and non-ischaemic cardiomyopathy. 1 Even though LGE informs diagnosis and prognosis in ischaemic cardiomyopathy, 2 there is less concrete evidence that LGE is as useful in non-ischaemic cardiomyopathy, which is characterized by diffuse myocardial fibro-sis. This is because LGE interpretation relies on relative difference in signal intensity between 'normal' and 'abnormal' myocardium, although quantification using thresholds based on multiples of signal intensity standard deviation (SD) is possible. T 1 mapping has emerged as the most promising CMR technique for the identification and quantification of diffuse fibrosis. There is a growing body of observational data showing that differences exist in myocardial T 1 values between normal subjects and patients with a wide range of disease processes, including dilated or hypertrophic cardiomyopathy, 3 ischaemia, 4 amyloid, 5 iron overload, 6 Takotsubo cardiomyopathy, 7 and myocarditis. 8 T 1 values also identify subclinical
    European Heart Journal – Cardiovascular Imaging 10/2014; · 3.67 Impact Factor

Full-text (2 Sources)

Available from
Jun 5, 2014